Search Results

No Matching Results

    Recently Viewed

      Listening...

      Sorry, I don't understand. Please try again
      Home
      /
      Latest news
      /
      Innovation
      /
      Innovation-opedia: What is a mosaic vaccine?
      Graphic featuring a syringe to illustrate an HIV vaccine trial
      Innovation

      Innovation-opedia: What is a mosaic vaccine?

      As the IAS Conference on HIV Science kicks off in Mexico City, we explain how an investigational HIV vaccine from the Janssen Pharmaceutical Companies of Johnson & Johnson works—and how researchers hope to help change lives around the world with it.

      Written by Johnson & Johnson
       | July 22, 2019
      July 22, 2019
      Share Article
      share to
      Illustrated handwritten definition of a mosaic HIV vaccine
      Illustration of a microscope with information about Janssen Vaccines & Prevention B.V. investigational HIV-1 vaccine regimen
      Inset- Innovation-opedia: What Is a Mosaic Vaccine?- mosaic-vaccine-4-immunizations_above
      Illustration of the # 4 explaining how many injections would be administered for Janssen’s investigational HIV-1 vaccine.
      Inset- Innovation-opedia: What Is a Mosaic Vaccine?- mosaic-vaccine-4-immunizations_below
      Illustration showing location of the IAS Conference on HIV Science with details about Janssen’s new Mosaico clinical trial.
      Illustrated quote by Janssen’s Maria Grazia Pau talking about the goal of creating a global HIV vaccine.

      We’re committed to helping lead the fight against HIV/AIDS

      Read about the many ways Johnson & Johnson is working to #makeHIVhistory.
      Learn more
      CTA-Red ribbon HIV

      HIV vaccine HIV/AIDS J&J Innovative Medicine Johnson & Johnson

      More from Johnson & Johnson

      Health & wellness
      July 18, 2024

      By the numbers: Understanding dry eye disease

      For National Dry Eye Awareness Month, learn about the causes of this common condition and how Johnson & Johnson is helping to find treatment options.
      Read more
      Latest news
      July 17, 2024

      What you need to know about Johnson & Johnson’s 2024 second quarter earnings

      Read more
      Latest news
      July 9, 2024

      What to know about We All Belong: 2023 DEI Impact Review

      The annual report details how Johnson & Johnson is harnessing the power of diversity, equity and inclusion to provide better care around the world.
      Read more
      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
      Continue